Search Results - Julius Keyl

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    ABO‐Blood Group Associates With Survival Outcomes in Patients With Metastatic Non‐Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy by Franziska Certa, Peter A. Horn, Julius Keyl, Bastian Mende, Smiths Lueong, Thomas Hilser, Sarah Theurer, Isabel Virchow, Yasmin Zaun, Michael Pogorzelski, Martin Metzenmacher, Halime Kalkavan, Stefan Kasper, Martin Schuler, Marcel Wiesweg, Gregor Zaun

    Published in Thoracic Cancer (2025-03-01)
    Get full text
    Article


  2. 2

    Deep learning‐based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer by Julius Keyl, René Hosch, Aaron Berger, Oliver Ester, Tobias Greiner, Simon Bogner, Jürgen Treckmann, Saskia Ting, Brigitte Schumacher, David Albers, Peter Markus, Marcel Wiesweg, Michael Forsting, Felix Nensa, Martin Schuler, Stefan Kasper, Jens Kleesiek

    Published in Journal of Cachexia, Sarcopenia and Muscle (2023-02-01)
    Get full text
    Article


  3. 3

    1294 External validation of machine learning models to predict efficacy and toxicity of immune checkpoint inhibitors using real-world pan cancer cohorts by Jens Siveke, Alexander Roesch, Viktor Grünwald, Zoltan Kiss, Jan Wolber, Martin Schuler, Julius Keyl, Levente Lippenszky, Pablo Napan-Molina, Eszter Csernai, Travis Osterman, Balazs Laczi, Alexander Brehmer, Moon Kim, Moritz Meyer, Stefan Kasper, Jens Kleesiek

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  4. 4

    Establishing Medical Intelligence—Leveraging Fast Healthcare Interoperability Resources to Improve Clinical Management: Retrospective Cohort and Clinical Implementation Study by Alexander Brehmer, Christopher Martin Sauer, Jayson Salazar Rodríguez, Kelsey Herrmann, Moon Kim, Julius Keyl, Fin Hendrik Bahnsen, Benedikt Frank, Martin Köhrmann, Tienush Rassaf, Amir-Abbas Mahabadi, Boris Hadaschik, Christopher Darr, Ken Herrmann, Susanne Tan, Jan Buer, Thorsten Brenner, Hans Christian Reinhardt, Felix Nensa, Michael Gertz, Jan Egger, Jens Kleesiek

    Published in Journal of Medical Internet Research (2024-10-01)
    Get full text
    Article


  5. 5

    Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma by Christian Klein, Daria Briukhovetska, Michael von Bergwelt-Baildon, Sebastian Kobold, Mitchell P Levesque, Bruno L Cadilha, Stefan Endres, Mohamed-Reda Benmebarek, Hannah Obeck, Sophia Stock, Florian Märkl, Julius Keyl, Martina Geiger, Clara Karches, Melanie Schwerdtfeger, Stefanos Michaelides, Jakob Jobst, Philipp Jie Müller, Lina Majed, Matthias Seifert, Anna-Kristina Klüver, Theo Lorenzini, Ruth Grünmeier, Moritz Thomas, Adrian Gottschlich, Richard Klaus, Carsten Marr, Simon Rothenfusser, Markus Vincent Heppt

    Published in Journal for ImmunoTherapy of Cancer (2023-05-01)
    Get full text
    Article


  6. 6

    Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratification by Katarzyna Borys, Johannes Haubold, Julius Keyl, Maria A. Bali, Riccardo De Angelis, Kévin Brou Boni, Nicolas Coquelet, Judith Kohnke, Giulia Baldini, Lennard Kroll, Sara Schramm, Andreas Stang, Eugen Malamutmann, Jens Kleesiek, Moon Kim, Stefan Kasper, Jens T. Siveke, Marcel Wiesweg, Anja Merkel-Jens, Benedikt M. Schaarschmidt, Viktor Gruenwald, Sebastian Bauer, Arzu Oezcelik, Servet Bölükbas, Ken Herrmann, Rainer Kimmig, Stephan Lang, Jürgen Treckmann, Martin Stuschke, Boris Hadaschik, Lale Umutlu, Michael Forsting, Dirk Schadendorf, Christoph M. Friedrich, Martin Schuler, René Hosch, Felix Nensa

    Published in npj Digital Medicine (2025-10-01)
    Get full text
    Article


Search Tools: